(-0.10%) 5 017.36 points
(0.02%) 37 762 points
(-0.22%) 15 649 points
(0.54%) $83.14
(2.45%) $1.754
(0.59%) $2 402.60
(0.26%) $28.48
(0.03%) $954.50
(0.25%) $0.939
(0.50%) $11.05
(0.13%) $0.804
(0.10%) $94.15
Live Chart Being Loaded With Signals
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States...
Stats | |
---|---|
Today's Volume | 400.00 |
Average Volume | 9 264.00 |
Market Cap | 11.78M |
EPS | $0 ( 2024-03-29 ) |
Next earnings date | ( $0 ) 2024-05-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.42 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-11 | Osman Ronald E | Buy | 25 000 | Common Stock |
2023-05-05 | Ronald E Osman Irrevocable Trust Iii | Sell | 0 | Common Stock |
2023-05-05 | Tpb 2012 Llc | Buy | 0 | Common Stock |
2023-05-05 | Tpb 2012 Llc | Sell | 0 | Common Stock |
2023-05-05 | Mcnulty James A | Buy | 20 101 057 | Common Stock |
INSIDER POWER |
---|
-57.75 |
Last 91 transactions |
Buy: 128 793 757 | Sell: 121 688 284 |
Inhibitor Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Inhibitor Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.0176 |
Q4 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.00680 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.00390 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.00380 |
Financial Reports:
No articles found.
Inhibitor Therapeutics,
Inhibitor Therapeutics, Inc., a pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States. It engages in the development of therapies for prostate and lung cancer utilizing SUBA-Itraconazole, an oral formulation of the drug itraconazole; and conducted a positive Phase 2b study of SUBA-Itraconazole for the treatment of basal cell carcinoma nevus syndrome. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics, Inc. in August 2019. Inhibitor Therapeutics, Inc. was founded in 1992 and is based in Tampa, Florida.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators